CEP55: an immune-related predictive and prognostic molecular biomarker for multiple cancers
Abstract Background Centrosomal protein 55 (CEP55) plays a significant role in specific cancers. However, comprehensive research on CEP55 is lacking in pan-cancer. Methods In-house and multi-center samples (n = 15,823) were used to analyze CEP55 in 33 cancers. The variance of CEP55 expression levels...
Main Authors: | Guo-Sheng Li, Wei Zhang, Wan-Ying Huang, Rong-Quan He, Zhi-Guang Huang, Xiang-Yu Gan, Zhen Yang, Yi-Wu Dang, Jin-Liang Kong, Hua-Fu Zhou, Gang Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-05-01
|
Series: | BMC Pulmonary Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12890-023-02452-1 |
Similar Items
-
CEP55 is a determinant of cell fate during perturbed mitosis in breast cancer
by: Murugan Kalimutho, et al.
Published: (2018-09-01) -
Data mining combined with experiments to validate CEP55 as a prognostic biomarker in colorectal cancer
by: Kang Lin, et al.
Published: (2021-03-01) -
CEP55 as a Promising Immune Intervention Marker to Regulate Tumor Progression: A Pan-Cancer Analysis with Experimental Verification
by: Gang Wang, et al.
Published: (2023-10-01) -
A Comprehensive Pan-Cancer Analysis Identifies CEP55 as a Potential Oncogene and Novel Therapeutic Target
by: Mohamed Samir A. Zaki, et al.
Published: (2023-05-01) -
Cancer-testis antigen CEP55 serves as a prognostic biomarker and is correlated with immune infiltration and immunotherapy efficacy in pan-cancer
by: Xiaodong Xie, et al.
Published: (2023-07-01)